Author

Li-Mou Zheng

Observed names: L. Zheng, Li-mou Zheng, Limou Zheng

Institution: Xiamen University

Observed institutions: Tongji University, Xiamen University, First Affiliated Hospital of Xiamen University, Peking University Cancer Hospital, Shanghai Pulmonary Hospital, University of Colorado Cancer Center

OpenAlex ID: A5112718182

Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma

2015 · Weijing Cai, Dongmei Lin, et al. · Journal of Clinical Oncology · 135

ROS1 fusions in Chinese patients with non-small-cell lung cancer

2013 · W. Cai, X. Li, et al. · Annals of Oncology · 86

KIF5B‐RET fusions in Chinese patients with non–small cell lung cancer

2013 · Weijing Cai, Chunxia Su, et al. · Cancer · 57

Analysis of Driver Mutations in Female Non-Smoker Asian Patients with Pulmonary Adenocarcinoma

2012 · Shengxiang Ren, Peng Kuang, et al. · Cell Biochemistry and Biophysics · 57

Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never‐smoker women with pulmonary adenocarcinoma

2012 · Shengxiang Ren, Xiaoxia Chen, et al. · Cancer · 57

Transtinib, a potent tyrosine kinase inhibitor inhibits L858R/T790M mutant NSCLC cell lines and xenografts

2016 · Peng Hu, Da-xiong Han, et al. · Oncotarget · 2

[EGFR mutation status in Uighur lung adenocarcinoma patients].

2013 · Li Shan, Yan Zhang, et al. · Europe PMC (PubMed Central) · 1

[Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].

2013 · Hai-ping Zhang, Li Ruan, et al. · PubMed · 1

Oncogenic Driver Mutations in Chinese Non-Small Cell Lung Cancer (NSCLC)

2012 · J. He, H. Yang, et al. · Annals of Oncology

Works count: 9

Citation count: 396

H-index: 5

I10-index: 5